Weinberg Uri, Chief Medical and Innovation Officer at NovoCure Ltd. ($NVCR), sold shares on the open market three times in the last 365 days for a total of $232,178. His most recent sale occurred on March 4, 2026. These sales rank 8,106th among 11,678 individual insiders in our database, where the average sale amount is $8.6 million across about 6.4 transactions per insider. Weinberg Uri made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | NovoCure Ltd | $NVCR | Weinberg Uri | Chf Medical and Innovation Ofr | A | Ordinary Shares | 50125 | $0.00 | 273,602.0000 | 111,981,981 | 22.43% | 0.04% |
| March 4, 2026 | NovoCure Ltd | $NVCR | Weinberg Uri | Chf Medical and Innovation Ofr | S | Ordinary Shares | 6412 | $13.31 | 267,190.0000 | 111,981,981 | 2.34% | 0.01% |
| March 3, 2026 | NovoCure Ltd | $NVCR | Weinberg Uri | Chf Medical and Innovation Ofr | A | Stock Option (Right to Buy) | 73340 | $0.00 | 73,340.0000 | 111,981,981 | 9999.99% | 0.07% |
| March 2, 2026 | NovoCure Ltd | $NVCR | Weinberg Uri | Chf Medical and Innovation Ofr | S | Ordinary Shares | 3272 | $13.33 | 223,477.0000 | 111,981,981 | 1.44% | 0.00% |
| Feb. 28, 2026 | NovoCure Ltd | $NVCR | Weinberg Uri | Chf Medical and Innovation Ofr | A | Ordinary Shares | 12992 | $0.00 | 226,749.0000 | 111,981,981 | 6.08% | 0.01% |
| Feb. 27, 2026 | NovoCure Ltd | $NVCR | Weinberg Uri | Chf Medical and Innovation Ofr | S | Ordinary Shares | 7461 | $13.84 | 213,757.0000 | 111,981,981 | 3.37% | 0.01% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 54975 | $18.19 | 221,218.0000 | 109,915,429 | 33.07% | 0.05% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 3, 2025 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | S | Ordinary Shares | 268 | $18.92 | 166,243.0000 | 109,915,429 | 0.16% | 0.00% |
| Feb. 28, 2025 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | S | Ordinary Shares | 311 | $18.31 | 166,511.0000 | 109,915,429 | 0.19% | 0.00% |
| Feb. 28, 2025 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | S | Ordinary Shares | 4326 | $18.78 | 166,822.0000 | 109,915,429 | 2.53% | 0.00% |
| Feb. 28, 2025 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | S | Ordinary Shares | 311 | $18.31 | 166,511.0000 | 109,915,429 | 0.19% | 0.00% |
| Feb. 28, 2025 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | S | Ordinary Shares | 4326 | $18.78 | 166,822.0000 | 109,915,429 | 2.53% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | A | Stock Options (Right to buy) | 125078 | $16.30 | 125,078.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 81799 | $16.30 | 171,148.0000 | 0 | 91.55% | 0.00% |
| June 30, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 305 | $35.28 | 89,349.0000 | 0 | 0.34% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 3936 | $0.00 | 89,044.0000 | 0 | 4.62% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 28830 | $0.00 | 85,108.0000 | 0 | 51.23% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | A | Ordinary Shares | 12992 | $0.00 | 56,278.0000 | 0 | 30.01% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Innovation Officer | A | Options to Buy Ordinary Shares | 21607 | $76.97 | 21,607.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Science Officer | S | Ordinary Shares | 2379 | $120.00 | 47,104.0000 | 0 | 4.81% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Science Officer | S | Ordinary Shares | 1946 | $120.00 | 47,104.0000 | 0 | 3.97% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Science Officer | S | Ordinary Shares | 2617 | $108.00 | 44,487.0000 | 0 | 5.56% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Science Officer | S | Ordinary Shares | 1201 | $120.00 | 43,286.0000 | 0 | 2.70% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Science Officer | M | Options to Buy Ordinary Shares | 1946 | $0.00 | 1,946.0000 | 0 | 50.00% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Weinberg Uri | Chief Science Officer | M | Ordinary Shares | 1946 | $47.04 | 49,050.0000 | 0 | 4.13% | 0.00% |